Infection prevention market brochure

To Enquire About the Report Click Here

IndustryARC

Infection prevention & Control Market (2014-2020)

By Infections (Microbial and Others); By Antimicrobial Drugs (Antibacterial and Others); By Accessories and Equipment (Disinfectants and Others); By End User (Equipment and drug usage) & By Geography

To Enquire About the Report Click Here

Table of Contents 1. Global Infection Prevention & Control - Market Overview 2. Global Infection Prevention & Control Market - Executive Summary 3. Global Infection Prevention & Control - Market Landscape 3.1. Market share Analysis 3.2. Comparative Analysis 3.2.1.

Product Benchmarking

3.2.2.

End-User Profiling

3.2.3.

Patent Analysis

3.2.4.

Top 5 Financial Analysis

4. Global Infection Prevention & Control - Market Forces 4.1. Market Drivers 4.2. Market Constraints 4.3. Market Challenges 4.4. Attractiveness of the Industry 4.4.1.

Power of Suppliers

4.4.2.

Power of Customers

4.4.3.

Threat of New entrants

4.4.4.

Threat of Substitution

4.4.5.

Degree of Competition

5. Global Infection Prevention & Control Market – Strategic Analysis

5.1. Value Chain Analysis 5.2. Opportunity Analysis 5.3. Product Life Cycle Analysis

To Enquire About the Report Click Here

5.4. Pricing Analysis 6. Global Infection Prevention & Control Market – By Infections 6.1. Microbial Infections 6.1.1.

Bacterial Infection

6.1.1.1.

Mycobacterium tuberculosis

6.1.1.2.

Clostridium Difficile

6.1.1.3.

E. Coli

6.1.1.4.

Helicobacter pylori

6.1.1.5.

Salmonella

6.1.1.6.

Others

6.1.2.

Viral Infection

6.1.2.1.

Ebola Virus

6.1.2.2.

Human Immunodeficiency Virus (HIV)

6.1.2.3.

Herpes Simplex Virus

6.1.2.4.

Yellow Fever

6.1.2.5.

Dengue Viruses

6.1.2.6.

Others

6.1.3.

Fungal Infection

6.1.3.1.

Cryptococcus gattii

6.1.3.2.

Aspergillis

6.1.3.3.

PCP: Pneumocystis Pneumonia

6.1.3.4.

Fungal Keratitis

6.1.3.5.

Dermatophytes

6.1.3.6.

Others

To Enquire About the Report Click Here

6.2. Healthcare Associated Infection 6.2.1.

Hospital Acquired Infection

6.2.1.1.

Central Line-associated Bloodstream Infection (CLABSI)

6.2.1.2.

Catheter-associated Urinary Tract Infection

6.2.1.3.

Surgical Site Infection

6.2.1.4.

Ventilator-associated Pneumonia (VAP) Infection

6.2.2.

Community acquired Infection

6.2.2.1.

Methicillin-resistant Staphylococcus aureus (MRSA) infection

6.2.2.2.

Community-acquired pneumonia

7. Global Infection Prevention & Control Market - By Anti-Microbial Drugs 7.1. Anti- Bacterial Drugs 7.2. Anti- Viral Drugs 7.3. Anti-fungal Drugs 7.4. Vaccines 8. Infection Prevention & Control Market - By Accessories and Equipment 8.1. Personal Protective Equipment 8.1.1.

Gloves

8.1.2.

Surgical Masks & Respirators

8.1.3.

Surgical Drapes & Gown

8.1.4.

Surgical Foot Covers

8.1.5.

Medical Safety Glasses

8.1.6.

Others

8.2. Disinfectants 8.2.1.

Hand Sanitizers

To Enquire About the Report Click Here

8.2.2.

Disinfectant Wipes

8.2.3.

Surface Disinfectants

8.2.4.

Instrument Disinfectants

8.2.5.

Surgical Disinfectants

8.2.6.

Environmental Disinfectants

8.2.7.

Others

8.3. Sterilization 8.3.1.

Medical Device Sterilization Equipment

8.3.1.1.

Wet/ Steam Sterilization (Autoclave)

8.3.1.1.1.

Vertical Autoclave

8.3.1.1.2.

Horizontal Autoclave

8.3.1.1.3.

Portable Autoclave

8.3.1.2.

Dry Heat Sterilization

8.3.1.3.

Low Temperature Sterilization

8.3.1.3.1.

In-House Steam Sterilization

8.3.1.3.2.

Ethylene Oxide (EO) Sterilization

8.3.1.3.3.

Gamma and eBeam Sterilization

9. Global Infection Prevention & Control Market - By End User Industry

9.1. End Users: By Equipment Usage 9.1.1.

Hospitals & Clinics

9.1.2.

Medical laboratories

9.1.3.

Manufacturing Units

9.1.3.1.

Pharmaceuticals

9.1.3.2.

Medical Devices

To Enquire About the Report Click Here

9.1.3.3.

Food & Beverages Industry

9.2. End Users: By Drug Usage 9.2.1.

Individuals & Patients

9.2.2.

Nursing & Senior care Centers

10. Global Infection Prevention & Control Market – Regulatory Scenario 11. Global Infection Prevention & Control Market - Geographic Analysis 11.1.

Introduction

11.2.

North America 11.2.1. US 11.2.2. Canada 11.2.3. Mexico 11.2.4. Others

11.3.

Europe 11.3.1. France 11.3.2. Germany 11.3.3. Italy 11.3.4. Spain 11.3.5. UK 11.3.6. Others

11.4.

APAC 11.4.1. China 11.4.2. India 11.4.3. Japan 11.4.4. Korea

To Enquire About the Report Click Here

11.4.5. Others 11.5.

ROW 11.5.1. Saudi Arabia 11.5.2. South Africa 11.5.3. Brazil 11.5.4. Russia

11.5.5. Others

12. Market Entropy 12.1.

New Product Launches

12.2.

M&As, Collaborations, JVs and Partnerships

13. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolios) 13.1.

ABBOTT LABORATORIES (ABBOTT DIACNOSTICS)

13.2.

ALERE

13.3.

ANSELL LIMITED

13.4.

ASTRAZENECEA

13.5.

BARD (CR) INCORPORATED

13.6.

BECTON, DICKINSON AND COMPANY

13.7.

BELIMED

13.8.

CANTEL

13.9.

COVIDIEN PLC

13.10. GETINGE GROUP 13.11. HOLLISTER INCORPORATED 13.12. JOHNSON & JOHNSON

To Enquire About the Report Click Here

13.13. KIMBERLY-CLARK 13.14. MERCK & CO 13.15. PFIZER 13.16. ROCHE 13.17. SIEMENS AG 13.18. SUPERMAX CORPORATION 13.19. TERUMO CORPORATION 13.20. 3M COMPANY 14. Appendix 14.1.

Abbreviations

14.2.

Sources

14.3.

Research Methodology

14.4.

Bibliography

14.5.

Compilation of Expert Insights

14.6.

Disclaimer

To Enquire About the Report Click Here

LIST OF TABLES Table 1 Product Benchmarking for Global Infection Prevention & Control Market – By Products and Pricing ($) Table 2 Top Five Financial Analysis for Global Infection Prevention & Control Market ($M) Table 3 Global Infection Prevention & Control Market Revenue, By Microbial Infections, 20142020 ($bn) Table 4 North America Infection Prevention and Control Market Revenue, By Microbial Infections, 2014-2020 ($bn) Table 5 Europe Infection Prevention and Control Market Revenue, By Microbial Infections, 20142020 ($bn) Table 6 APAC Infection Prevention and Control Market Revenue, By Microbial Infections, 20142020 ($bn) Table 7 RoW Infection Prevention and Control Market Revenue, By Microbial Infections, 20142020 ($bn) Table 8 Global Infection Prevention & Control Market Revenue, By Healthcare Associated Infections, 2014-2020 ($bn) Table 9 North America Infection Prevention and Control Market Revenue, By Healthcare Associated Infections, 2014-2020 ($bn) Table 10 Europe Infection Prevention and Control Market Revenue, By Healthcare Associated Infections, 2014-2020 ($bn) Table 11 APAC Infection Prevention and Control Market Revenue, By Healthcare Associated Infections, 2014-2020 ($bn) Table 12 RoW Infection Prevention and Control Market Revenue, By Healthcare Associated Infections, 2014-2020 ($bn) Table 13 Global Infection Prevention & Control Market Revenue, By Anti-Microbial Drugs, 20142020 ($bn) Table 14 North America Infection Prevention and Control Market Revenue, By Anti-Microbial Drugs, 2014-2020 ($bn) Table 15 Europe Infection Prevention and Control Market Revenue, By Anti-Microbial Drugs, 2014-2020 ($bn) Table 16 APAC Infection Prevention and Control Market Revenue, By Anti-Microbial Drugs, 2014-2020 ($bn)

To Enquire About the Report Click Here

Table 17 RoW Infection Prevention and Control Market Revenue, By Anti-Microbial Drugs, 20142020 ($bn) Table 18 Global Infection Prevention & Control Market Revenue, By Personal Protective Equipment, 2014-2020 ($bn) Table 19 North America Infection Prevention and Control Market Revenue, By Personal Protective Equipment, 2014-2020 ($bn) Table 20 Europe Infection Prevention and Control Market Revenue, By Personal Protective Equipment, 2014-2020 ($bn) Table 21 APAC Infection Prevention and Control Market Revenue, By Personal Protective Equipment, 2014-2020 ($bn) Table 22 RoW Infection Prevention and Control Market Revenue, By Personal Protective Equipment, 2014-2020 ($bn) Table 23 Global Infection Prevention & Control Market Revenue, By Disinfectants, 2014-2020 ($bn) Table 24 North America Infection Prevention and Control Market Revenue, By Disinfectants, 2014-2020 ($bn) Table 25 Europe Infection Prevention and Control Market Revenue, By Disinfectants, 2014-2020 ($bn) Table 26 APAC Infection Prevention and Control Market Revenue, By Disinfectants, 2014-2020 ($bn) Table 27 RoW Infection Prevention and Control Market Revenue, By Disinfectants, 2014-2020 ($bn) Table 28 Global Infection Prevention & Control Market Revenue, Sterilization, 2014-2020 ($bn) Table 29 North America Infection Prevention and Control Market Revenue, By Sterilization, 20142020 ($bn) Table 30 Europe Infection Prevention and Control Market Revenue, By Sterilization, 2014-2020 ($bn) Table 31 APAC Infection Prevention and Control Market Revenue, By Sterilization, 2014-2020 ($bn) Table 32 RoW Infection Prevention and Control Market Revenue, By Sterilization, 2014-2020 ($bn)

To Enquire About the Report Click Here

Table 33 Global Infection Prevention & Control Market Revenue, By Equipment Usage End Users, 2014-2020 ($bn) Table 34 North America Infection Prevention and Control Market Revenue, By Equipment Usage End Users, 2014-2020 ($bn) Table 35 Europe Infection Prevention and Control Market Revenue, By Equipment Usage End Users, 2014-2020 ($bn) Table 36 APAC Infection Prevention and Control Market Revenue, By Equipment Usage End Users, 2014-2020 ($bn) Table 37 RoW Infection Prevention and Control Market Revenue, By Equipment Usage End Users, 2014-2020 ($bn) Table 38 Global Infection Prevention & Control Market Revenue, By Drug Usage End Users, 2014-2020 ($bn) Table 39 North America Infection Prevention and Control Market Revenue, By Drug Usage End Users, 2014-2020 ($bn) Table 40 Europe Infection Prevention and Control Market Revenue, By Drug Usage End Users, 2014-2020 ($bn) Table 41 APAC Infection Prevention and Control Market Revenue, By Drug Usage End Users, 2014-2020 ($bn) Table 42 RoW Infection Prevention and Control Market Revenue, By Drug Usage End Users, 2014-2020 ($bn) Table 43 Global Anti-Microbial Drugs in Infection Prevention & Control Market Revenue, By Geography, 2014-2020 ($bn) Table 44 North America Anti-Microbial Drugs in Infection Prevention & Control Market, By Country, 2014-2020 (bn) Table 45 Europe Anti-Microbial Drugs in Infection Prevention & Control Market, By Country, 2014-2020 (bn) Table 46 APAC Anti-Microbial Drugs in Infection Prevention & Control Market, By Country, 2014-2020 (bn) Table 47 RoW Anti-Microbial Drugs in Infection Prevention & Control Market, By Country, 20142020 (bn) Table 48 Global Equipment and Accessories in Infection Prevention & Control Market Revenue,

By Geography, 2014-2020 ($bn)

To Enquire About the Report Click Here

Table 49 North America Equipment and Accessories in Infection Prevention & Control Market,

By Country, 2014-2020 (bn) Table 50 Europe Equipment and Accessories in Infection Prevention & Control Market, By Country, 2014-2020 (bn) Table 51 APAC Equipment and Accessories in Infection Prevention & Control Market, By Country, 2014-2020 (bn) Table 52 RoW Equipment and Accessories in Infection Prevention & Control Market, By Country, 2014-2020 (bn)

To Enquire About the Report Click Here

LIST OF FIGURES Figure1 Global Infection Prevention & Control Market, By Geography, 2014 - 2020 ($M) Figure2 Segmentation of Global Infection Prevention & Control Market Figure3 Global Infection Prevention & Control Market Competitive Share Analysis, 2014(%) Figure4 Global Infection Prevention & Control Share, By Infection, 2014 (%) Figure5 Global Infection Prevention & Control Market Share, By Anti-microbial Drugs, 2014 (%) Figure6 Global Infection Prevention & Control Market Share, By Accessories and Equipment, 2014 (%) Figure7 Global Infection Prevention & Control Market Share, By End User Industry, 2014 (%) Figure8 Global Infection Prevention & Control Market Share, By Geography, 2014 (%) Figure9 North America Infection Prevention & Control Market Share, By Country, 2014 (%) Figure10 Europe Infection Prevention & Control Market Share, By Country, 2014 (%) Figure11 APAC Infection Prevention & Control Market Share, By Country, 2014 (%) Figure12 RoW Infection Prevention & Control Market Share, By Country, 2014 (%) Figure13 Global Infection Prevention & Control Market Recent Developments, By Year, 20122015

To Enquire About the Report Click Here

REPORT SCOPE The global market for infection prevention & control has been segmented by the types of infections, types of anti-microbial drugs, type of equipment and accessories and end-user industry. The infections occurring from bacteria, viruses and fungi and the various types of anti-microbial drugs administered for control of infections have been taken into account for the market analysis and forecast. Each of these segmentations has been sub-segmented and studied in detail to give a comprehensive analysis of the global infection prevention & control market.

The overall market has also been presented from the perspective of different geographic locations into standard geographic regions and key economies for this market. Competitive landscape for each of the capture technologies and storage methods is highlighted and the market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided. The prominent players profiled in this report are Johnson & Johnson, Inc., Roche, 3M Company, AstraZeneca Plc., Kimberly-Clark and others.

The report contains the most detailed and in-depth segmentation and analysis of the global infection prevention & control market during the period 2014 - 2020.

Stakeholders

The following are the prominent stakeholders in the global market for infection prevention & control.

•

Original Equipment Manufacturers (OEMs)

•

Infection Prevention products manufacturing companies

•

Hospitals and Clinics

•

Pharmaceutical Companies

•

Healthcare Insurance Players

•

Distributors, Suppliers and Retailers

•

Hospitals, Clinics and Research Centers

•

Regulatory authorities

To Enquire About the Report Click Here

EXECUTIVE SUMMARY Infection prevention and Control (IPC) is a rapidly growing field in the healthcare industry. The proper usage of the IPC products all across the globe has the potential to revolutionize the complete healthcare industry, making it disease free. The market opportunity for IPC is promising, yet conflicting financial Incentives has created uncertainty on how stakeholders can capitalize. The market for Infection prevention is estimated to increase with a CAGR of 5.3% during the forecast period 2015-2020. Infection prevention and control market is experiencing significant growth with the increase in awareness among the people, elderly & aging population, and number of surgeries and proper donning and doffing of Hospital Housekeeper which prevents in the spread of the contagious waste.

Infection prevention and control is the major and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals, and food & beverage industries.

The adoption of various means of personal protective equipment, disinfection, sterilization and inhouse sterilization procedures by hospitals and end users industries has revolutionized the healthcare industry. Sterilization and disinfection protect different products and materials from being contaminated by microbes. The disinfection and sterilization market is going to expand with a CAGR of 6.2% during the period under study. The integration of technologies into traditional healthcare systems is one of the most influencing trends that will drive the growth of this market.

The technological advancements will facilitate the availability and implementation of cost-effective technologies across a range of healthcare facilities. The introduction of technically enhanced instruments likes portable autoclaves, In-House & ethylene oxide (EtO) advanced sterilization and so on has resulted in the drastic swing from the previous used equipment’s such as steam sterilizer.

SAMPLE TABLE: NORTH AMERICA INFECTION PREVENTION AND CONTROL MARKET, BY ANTI-MICROBIAL DRUGS, 2014–2020 ($BN) North America

2013

2014

2015

Anti- Bacterial Drugs xx xx xx Anti- Viral Drugs xx xx xx Vaccines xx xx xx Anti-fungal Drugs xx xx xx Total xx xx xx Source: IndustryARC Analysis, Expert Insights

2016

2017

2018

2019

2020

xx xx xx xx xx

xx xx xx xx xx

xx xx xx xx xx

xx xx xx xx xx

xx xx xx xx xx

CAGR% (20142020) xx% xx% 4.8% xx% 4.5%

To Enquire About the Report Click Here

The IPC market by anti-microbial drugs in North America in 2014 was valued at $XX billion and is projected to grow at a CAGR of 4.5% during the forecast period. The North American region has been concentrating on relatively easy commercial drugs which were driven by the increase in chronic diseases. This has led to the development of vaccines, since these are specific for a particular infection. The cost of the vaccines varies as per the infected microbes. Thus, followed by antibacterial drugs, vaccines show the highest growth rate of 4.8% towards the increasing demand of anti-microbial drugs, where most patients would be managed with a short course of therapy in comparison to the generic antibiotics. According to the World Health Organization, 30.85% of the globally registered hospitals are in the Americas. Moreover, the rapidly aging population in the U.S., Canada and Mexico will drive the need for efficient anti-microbial drugs in hospitals and senior care centres in this region.

SAMPLE FIGURE: GLOBAL INFECTION PREVENTION & CONTROL MARKET REVENUE, BY MICROBIAL INFECTIONS, 2014 (%)

Bacterial Infections Viral Infections Fungal Infections

Source: IndustryARC Analysis, Expert Insights

The global infection prevention and control market is segmented into bacterial, fungal and viral infections based on the types of microbial infections. In 2014, bacterial infections dominated the market with 44% of the global market share in infection prevention and control market, followed by viral infections, which occupied 39%.

To Enquire About the Report Click Here

KEY MARKET INSIGHTS •

The U.S. Centers for Disease Control and Prevention in January, 2015 has declared that the prevention and control of infections spread through hospitals has improved with the centralline associated bloodstream infections and infections resulting from surgical sites have dropped by a great deal from 2008 to 2013.

•

Pediatric Infectious Diseases Society (PIDS) in February, 2015 alarmed the people of the U.S. to get vaccinated for measles in view of the recent measles outbreak, which was almost swept off from the U.S. 15 years ago.

•

According to the results of a study published in January, 2015 in Infection Control and Hospital Epidemiology, the bundle approach adapted by Hong Kong Healthcare system to control and combat H7N9 influenza viral attack played a significant role in prevention of the infection.

•

In North America, the demand for Infection prevention and Control will increase with a CAGR of 4.3%, driven by the advancement in the technology and increasing awareness among growing population.

•

The demand for hand sanitizer has experienced a hue rise since the first instances of swine flu broke out and the recent Ebola virus outbreak and the hand Sanitizer market is estimated to mature with a CAGR of 7.04% in between the years 2015 and 2020.

To Enquire About the Report Click Here

RESEARCH METHODOLOGY The quantitative and qualitative data collected for the global infection prevention and control market report is from a combination of secondary and primary sources. Research interviews were conducted with executives and/or mangers in the key healthcare related organizations. These Key Opinion Leaders (KOLs) were then provided a questionnaire to gather quantitative and qualitative inputs on their operations, performance, strategies and views on the overall market, including key developments and trends. Data from interviews is consolidated, checked for consistency and accuracy, and the final market numbers are again validated by experts. The global infection prevention and control market was split by technology, material, application and geography based on different factors like primary and secondary sources, understanding of the number of companies operating in each segment and also KOL insights.

We have used various secondary sources such as directories, articles, white papers, newsletters, annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect information for extensive commercial study of the global infection prevention and control market.

The approach towards finding information regarding the market and forecasting has been quite extensive. The key players in the market and its value chain were identified through secondary research and their market opinions were also gathered in a similar way through telephonic interviews and questionnaires. Interviews with key opinion leaders such as managers and marketing personnel were used extensively in understanding the need and emergence of infection prevention and control market.

We also have extensive database of contacts which were used to conduct primary interviews and also to get their inputs using questionnaires.

To Enquire About the Report Click Here

THE ARC ADVANTAGE An analytical model lies at the core of our process, ensuring logical consistency throughout our research. We complement the model with secondary data and interviews with industry experts to reflect the latest trends. With our final expert validation, we provide you with only the most accurate and actionable intelligence.

THE ARC PROCESS Analytical Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market 3. Assign weights to these factors in terms of their relevance and impact on the market 4. Build the Analytical Model ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of the market 2. Follow it up with a bottom-up estimate of the market 3. Check forconsistency and new growth factors that are relevant over the next 10 Years

4. Build the Base model BASE MODEL

Consolidation Method 1. Granular breakdown of drivers into factors 2. Validate all factors in terms of their present impact on the market.

3. Assign weights to these factors in terms of their relevance and impact on the market.

4. Build the Consolidated Model

Delphi Verification 1. Verify the findings of the model with experts from across the value chain 2. Verify the findings with players across small and large enterprises 3. Tweak the model and add new factors 4. Finalize the ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About the Report Click Here

ABOUT US IndustryARC was started by a group of young, passionate professionals along with extensively experienced industry veterans across various business segments. Our focus and expertise is mainly in the field of analytics, market research and consulting. Our singular goal is to provide accurate and affordable research to our clients.

Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more! Seeing your business flourish based on our solutions and strategy is what we love the most!

IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.

Our reports are in-depth and high quality reports that can help decision makers frame better strategies for their business requirements. These reports can be further customized as per your needs.

Disclaimer: •

The reports sold by IndustryARC are limited publications containing valuable market information provided to a select group of customers in response to orders.

•

Our customers acknowledge and agree that any report bought from IndustryARC is for their own internal use and not for general publication or disclosure to third parties.

•

Our reports or part of the reports, information contained in the report, cannot be shared or resold to any other third party.

•

Disclosure to third parties, usage of data in a public document, article or blog by the customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact: sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About the Report Click Here

IndustryARC +1 614 - 588 - 8538 sales@industryarc.com

Copyright Š2015 IndustryARC All Rights Reserved. This document contains highly confidential information and is the sole property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of IndustryARC.